Abstract
Central giant cell granulomas (CGCGs) are intraosseous, non-neoplastic in nature and unpredictable in their clinical behavior. The spectrum of their clinical behavior is wide, ranging from mild, slow growing, aggressive and to be locally destructive lesions. In fact, it is this element of unpredictability that makes it difficult for the clinicians to design the most appropriate treatment plan. Based on the aggressiveness of these lesions, treatment options may include surgical enucleation and curettage, and en-bloc resection in addition to medical treatment.